ICU sedation, delirium & recovery
Olanzapine for the Prevention and Treatment of Intensive Care Unit (ICU) Delirium: Protocol for a Systematic Review With Meta‐Analysis
Study context
- Population
- ICU patients
- Planned comparison
- Prophylactic or therapeutic olanzapine versus any comparator
- Primary endpoint
- Days alive and out of the hospital
Methodological detailsrandomized clinical trials (RCTs), trial sequential analysis (TSA), Cochrane Risk of Bias tool (RoB-2), Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach, PRISMA-P
- Randomized clinical trials (RCTs)
- Trial sequential analysis (TSA)
- Cochrane Risk of Bias tool (RoB-2)
- GRADE approach
- PRISMA-P
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Olanzapine for the Prevention and Treatment of ICU Delirium: Protocol for a Systematic Review With Meta‐Analysis. Acta Anaesthesiol Scand. Published 7 October 2026. doi:10. 1111/ aas. 70352
Composed by AI from the published abstract and checked against it. How Briefs are made →